Murae Organisor Ltd Stock Hits All-Time Low Amidst Prolonged Downtrend

Jan 30 2026 09:38 AM IST
share
Share Via
Shares of Murae Organisor Ltd, a player in the Pharmaceuticals & Biotechnology sector, have declined to an all-time low of Rs.0.2, marking a significant milestone in the stock’s extended downward trajectory despite recent positive earnings reports.
Murae Organisor Ltd Stock Hits All-Time Low Amidst Prolonged Downtrend

Stock Performance Overview

On 30 Jan 2026, Murae Organisor Ltd’s stock price settled at Rs.0.2, establishing a new 52-week and all-time low. The stock’s performance today was flat at 0.00%, outperforming the broader Pharmaceuticals & Biotechnology sector by 4.94%, while the Sensex declined by 0.50%. However, this short-term relative strength belies a much deeper decline over longer periods.

Over the past week, the stock has fallen by 9.09%, contrasting with a 0.75% gain in the Sensex. The one-month and three-month performances are identical at -28.57%, significantly underperforming the Sensex’s respective declines of -2.98% and -2.67%. The year-to-date return stands at -23.08%, compared to the Sensex’s -3.60%. Most notably, the stock has lost 90.29% over the last year, while the Sensex has gained 7.02%. The three-year and five-year returns are similarly stark, with losses of 90.09% and 97.09% respectively, against Sensex gains of 38.07% and 77.49%. Over a decade, the stock has remained flat, whereas the Sensex has surged 230.31%.

Murae Organisor is currently trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, indicating sustained downward momentum.

Handpicked from 50, scrutinized by experts – Our recent selection, this Mid Cap from Bank - Public, is already delivering results. Don't miss next month's pick!

  • - Expert-scrutinized selection
  • - Already delivering results
  • - Monthly focused approach

Get Next Month's Pick →

Financial Metrics and Valuation

Despite the stock’s steep decline, Murae Organisor Ltd has reported some encouraging financial results in recent quarters. The company declared very positive results in June 2025, with net profit growth of 161.05%. It has posted positive results for four consecutive quarters, with net sales for the latest six months reaching Rs.519.52 crores, representing an extraordinary growth rate of 225,778.26%. Quarterly profit after tax (PAT) stood at Rs.7.44 crores, a 295.7% increase compared to the previous four-quarter average. The highest quarterly earnings per share (EPS) recorded was Rs.0.07.

Return on capital employed (ROCE) is reported at 0.4, and the enterprise value to capital employed ratio is 0.6, suggesting a very attractive valuation relative to capital utilisation. The stock trades at a discount compared to its peers’ average historical valuations.

Credit and Fundamental Considerations

However, the company’s long-term fundamental strength remains weak, as it has not declared financial results in the last six months, raising concerns about transparency and reporting consistency. The debt servicing capacity is limited, with a high Debt to EBITDA ratio of 8.43 times, indicating significant leverage and potential strain on cash flows.

Majority shareholding is held by non-institutional investors, which may influence liquidity and trading dynamics.

Considering Murae Organisor Ltd? Wait! SwitchER has found potentially better options in Pharmaceuticals & Biotechnology and beyond. Compare this small-cap with top-rated alternatives now!

  • - Better options discovered
  • - Pharmaceuticals & Biotechnology + beyond scope
  • - Top-rated alternatives ready

Compare & Switch Now →

Mojo Score and Rating Update

Murae Organisor Ltd currently holds a Mojo Score of 37.0, categorised as a Sell grade. This represents a downgrade from its previous Hold rating, effective from 25 Aug 2025. The market capitalisation grade stands at 3, reflecting the company’s small-cap status and associated risk profile.

The downgrade reflects the combination of weak long-term fundamentals, high leverage, and the stock’s persistent underperformance relative to the broader market and sector peers.

Summary of Market Context

The Pharmaceuticals & Biotechnology sector has generally shown resilience, with the Sensex gaining 7.02% over the past year and 38.07% over three years. In contrast, Murae Organisor Ltd’s stock has declined sharply, losing over 90% in the last year and more than 97% over five years. This divergence highlights the company’s unique challenges within an otherwise growing sector.

While recent quarterly results have shown strong growth in sales and profits, these have not translated into positive stock performance, possibly due to concerns over financial disclosures and debt levels.

Trading and Technical Indicators

The stock’s position below all major moving averages indicates a sustained bearish trend. The lack of price recovery despite positive quarterly earnings suggests that market participants remain cautious. The flat daily price movement today, coupled with outperformance relative to the sector, may reflect a temporary stabilisation rather than a reversal.

Shareholding Pattern

Non-institutional investors hold the majority of shares, which may impact trading volumes and price volatility. The absence of significant institutional backing could limit the stock’s liquidity and market support.

Conclusion

Murae Organisor Ltd’s stock reaching an all-time low of Rs.0.2 underscores the severity of its prolonged decline amid a challenging financial and market environment. Despite recent positive earnings growth and attractive valuation metrics, the company’s weak fundamental strength, high leverage, and lack of recent financial disclosures have contributed to sustained investor caution and significant underperformance relative to the sector and broader market indices.

Investors and market watchers will continue to monitor the company’s financial reporting and debt management closely as key indicators of its ongoing market position.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News